Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs

Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs

The emergence and spread of drug-resistant <i>Plasmodium falciparum</i> parasites shed a serious concern on the worldwide control of malaria, the most important tropical disease in terms of mortality and morbidity. This situation has led us to consider the use of peptide-alkoxyamine deri...

Full description

Bibliographic Details
Main Authors: Ange W. Embo-Ibouanga, Michel Nguyen, Lucie Paloque, Mathilde Coustets, Jean-Patrick Joly, Jean-Michel Augereau, Nicolas Vanthuyne, Raphaël Bikanga, Naomie Coquin, Anne Robert, Gérard Audran, Jérôme Boissier, Philippe Mellet, Françoise Benoit-Vical, Sylvain R. A. Marque
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Molecules
Subjects:
alkoxyamine
drug resistance
prodrug
malaria
<i>Plasmodium</i>
Online Access:https://www.mdpi.com/1420-3049/29/6/1397

Internet

https://www.mdpi.com/1420-3049/29/6/1397

Similar Items